Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|May 13, 2010
Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapyElvin Blanco, Erik A Bey, Chalermchai Khemtong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapyLong Shan Li, Erik A Bey, Ying Dong, et al.
Cancer Research|April 26, 2012
An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosisXiumei Huang, Ying Dong, Erik A Bey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levelsKathryn E Reinicke, Erik A Bey, Melissa S Bentle, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiationHeon Joo Park, Ki-Jung Ahn, Seung-Do Ahn, et al.
Journal of Cellular Physiology|September 27, 2006
Mornings with Art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responsesErik A Bey, Shelly M Wuerzberger-Davis, John J Pink, et al.
Molecular Cancer Therapeutics|July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancersErik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
Antioxidants & Redox Signaling|February 12, 2014
Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancersLifen Cao, Long Shan Li, Christopher Spruell, et al.
Cancer Research|July 4, 2020
Y Chromosome LncRNA Are Involved in Radiation Response of Male Non-Small Cell Lung Cancer CellsTayvia Brownmiller, Jamie A Juric, Abby D Ivey, et al.
Cancer Cell|December 14, 2016
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase InhibitorsXiumei Huang, Edward A Motea, Zachary R Moore, et al.
Pageof 3